Outcome differences of starting Paxlovid for COVID-19 within or after five days of symptoms onset in the elderly: a retrospective study
Introduction: The study aimed to compare the outcomes of nirmatrelvir and ritonavir drug combination (Paxlovid) therapy in patients who received treatment within or after five days of COVID-19 confirmed in the elderly. Methodology: This was a single-center, retrospective cohort study of older COV...
Saved in:
| Main Authors: | Junjun Chen, Quanjun Yang, Xiaohong Xu, Xia Wu, Yonglong Han, Cheng Guo, Jiao Yang |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
The Journal of Infection in Developing Countries
2024-09-01
|
| Series: | Journal of Infection in Developing Countries |
| Subjects: | |
| Online Access: | https://jidc.org/index.php/journal/article/view/19265 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparison of the therapeutic effect of Paxlovid and Azvudine in the treatment of COVID-19: A retrospective study
by: Wei Yang, et al.
Published: (2024-12-01) -
Paxlovid for the treatment of COVID-19: a systematic review and meta-analysis
by: Yu Wang, et al.
Published: (2024-08-01) -
Paxlovid for the treatment of severe or critical COVID-19 in children
by: Linjuan Xiang, et al.
Published: (2025-07-01) -
Mitigating Paxlovid™-induced drug‒drug interaction toxicity: an in silico insight
by: Giang H. Ta, et al.
Published: (2024-11-01) -
Risk Factors for Seeking Medical Care Following Nirmatrelvir-Ritonavir (Paxlovid) Treatment for COVID-19: “Symptom Rebound”
by: Ashish Bhargava, et al.
Published: (2025-05-01)